nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CHRM3—Carbachol—glaucoma	0.108	0.144	CbGbCtD
Darifenacin—CHRM3—Pilocarpine—glaucoma	0.101	0.134	CbGbCtD
Darifenacin—CHRM1—Carbachol—glaucoma	0.0943	0.125	CbGbCtD
Darifenacin—CHRM1—Pilocarpine—glaucoma	0.0877	0.116	CbGbCtD
Darifenacin—CHRM2—Carbachol—glaucoma	0.087	0.115	CbGbCtD
Darifenacin—CHRM2—Pilocarpine—glaucoma	0.0809	0.107	CbGbCtD
Darifenacin—CYP2D6—Carteolol—glaucoma	0.0389	0.0515	CbGbCtD
Darifenacin—CYP2D6—Betaxolol—glaucoma	0.0263	0.0348	CbGbCtD
Darifenacin—CYP2D6—Methazolamide—glaucoma	0.0199	0.0264	CbGbCtD
Darifenacin—CYP3A4—Pilocarpine—glaucoma	0.0187	0.0248	CbGbCtD
Darifenacin—CYP2D6—Timolol—glaucoma	0.0169	0.0224	CbGbCtD
Darifenacin—CYP3A4—Brinzolamide—glaucoma	0.0147	0.0195	CbGbCtD
Darifenacin—CYP2D6—Clonidine—glaucoma	0.0144	0.0191	CbGbCtD
Darifenacin—CYP3A4—Dorzolamide—glaucoma	0.0142	0.0188	CbGbCtD
Darifenacin—CYP3A4—Methazolamide—glaucoma	0.0127	0.0168	CbGbCtD
Darifenacin—CYP3A4—Acetazolamide—glaucoma	0.0101	0.0134	CbGbCtD
Darifenacin—CYP3A4—Clonidine—glaucoma	0.00915	0.0121	CbGbCtD
Darifenacin—Oedema—Pilocarpine—glaucoma	0.000272	0.00115	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000272	0.00115	CcSEcCtD
Darifenacin—Infection—Pilocarpine—glaucoma	0.000271	0.00114	CcSEcCtD
Darifenacin—Nausea—Methazolamide—glaucoma	0.00027	0.00114	CcSEcCtD
Darifenacin—Dyspnoea—Brimonidine—glaucoma	0.000269	0.00114	CcSEcCtD
Darifenacin—Somnolence—Brimonidine—glaucoma	0.000268	0.00113	CcSEcCtD
Darifenacin—Mental disorder—Clonidine—glaucoma	0.000268	0.00113	CcSEcCtD
Darifenacin—Shock—Pilocarpine—glaucoma	0.000268	0.00113	CcSEcCtD
Darifenacin—Rhinitis—Betaxolol—glaucoma	0.000267	0.00113	CcSEcCtD
Darifenacin—Tachycardia—Pilocarpine—glaucoma	0.000266	0.00112	CcSEcCtD
Darifenacin—Dyspepsia—Brimonidine—glaucoma	0.000266	0.00112	CcSEcCtD
Darifenacin—Hallucination—Betaxolol—glaucoma	0.000265	0.00112	CcSEcCtD
Darifenacin—Pharyngitis—Betaxolol—glaucoma	0.000265	0.00112	CcSEcCtD
Darifenacin—Hyperhidrosis—Pilocarpine—glaucoma	0.000263	0.00111	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000263	0.00111	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Travoprost—glaucoma	0.000262	0.0011	CcSEcCtD
Darifenacin—Insomnia—Dorzolamide—glaucoma	0.000261	0.0011	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Brimonidine—glaucoma	0.000261	0.0011	CcSEcCtD
Darifenacin—Feeling abnormal—Acetazolamide—glaucoma	0.000259	0.00109	CcSEcCtD
Darifenacin—Hypersensitivity—Apraclonidine—glaucoma	0.000259	0.00109	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000258	0.00109	CcSEcCtD
Darifenacin—Pain—Brimonidine—glaucoma	0.000258	0.00109	CcSEcCtD
Darifenacin—Dyspnoea—Dorzolamide—glaucoma	0.000257	0.00108	CcSEcCtD
Darifenacin—Visual impairment—Betaxolol—glaucoma	0.000257	0.00108	CcSEcCtD
Darifenacin—Insomnia—Brinzolamide—glaucoma	0.000256	0.00108	CcSEcCtD
Darifenacin—Somnolence—Dorzolamide—glaucoma	0.000256	0.00108	CcSEcCtD
Darifenacin—Dyspnoea—Travoprost—glaucoma	0.000256	0.00108	CcSEcCtD
Darifenacin—Dyspepsia—Dorzolamide—glaucoma	0.000254	0.00107	CcSEcCtD
Darifenacin—Dyspnoea—Brinzolamide—glaucoma	0.000253	0.00107	CcSEcCtD
Darifenacin—Dyspepsia—Travoprost—glaucoma	0.000253	0.00107	CcSEcCtD
Darifenacin—Asthenia—Apraclonidine—glaucoma	0.000252	0.00106	CcSEcCtD
Darifenacin—Somnolence—Brinzolamide—glaucoma	0.000252	0.00106	CcSEcCtD
Darifenacin—Vision blurred—Clonidine—glaucoma	0.000251	0.00106	CcSEcCtD
Darifenacin—Erectile dysfunction—Timolol—glaucoma	0.000251	0.00106	CcSEcCtD
Darifenacin—Dyspepsia—Brinzolamide—glaucoma	0.00025	0.00105	CcSEcCtD
Darifenacin—Eye disorder—Betaxolol—glaucoma	0.000249	0.00105	CcSEcCtD
Darifenacin—Pruritus—Apraclonidine—glaucoma	0.000249	0.00105	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000248	0.00105	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Travoprost—glaucoma	0.000248	0.00105	CcSEcCtD
Darifenacin—Pain—Dorzolamide—glaucoma	0.000247	0.00104	CcSEcCtD
Darifenacin—Insomnia—Pilocarpine—glaucoma	0.000246	0.00104	CcSEcCtD
Darifenacin—Pain—Travoprost—glaucoma	0.000246	0.00104	CcSEcCtD
Darifenacin—Constipation—Travoprost—glaucoma	0.000246	0.00104	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000245	0.00103	CcSEcCtD
Darifenacin—Asthenia—Bimatoprost—glaucoma	0.000245	0.00103	CcSEcCtD
Darifenacin—Angioedema—Clonidine—glaucoma	0.000244	0.00103	CcSEcCtD
Darifenacin—Dyspnoea—Pilocarpine—glaucoma	0.000243	0.00103	CcSEcCtD
Darifenacin—Pain—Brinzolamide—glaucoma	0.000242	0.00102	CcSEcCtD
Darifenacin—Somnolence—Pilocarpine—glaucoma	0.000242	0.00102	CcSEcCtD
Darifenacin—Angiopathy—Betaxolol—glaucoma	0.000242	0.00102	CcSEcCtD
Darifenacin—Pruritus—Bimatoprost—glaucoma	0.000241	0.00102	CcSEcCtD
Darifenacin—Diarrhoea—Apraclonidine—glaucoma	0.000241	0.00102	CcSEcCtD
Darifenacin—Mediastinal disorder—Betaxolol—glaucoma	0.00024	0.00101	CcSEcCtD
Darifenacin—Dyspepsia—Pilocarpine—glaucoma	0.00024	0.00101	CcSEcCtD
Darifenacin—Syncope—Clonidine—glaucoma	0.000239	0.00101	CcSEcCtD
Darifenacin—Feeling abnormal—Dorzolamide—glaucoma	0.000238	0.001	CcSEcCtD
Darifenacin—Feeling abnormal—Travoprost—glaucoma	0.000237	0.000998	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000236	0.000995	CcSEcCtD
Darifenacin—Palpitations—Clonidine—glaucoma	0.000236	0.000994	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000235	0.000993	CcSEcCtD
Darifenacin—Gastrointestinal pain—Travoprost—glaucoma	0.000235	0.000991	CcSEcCtD
Darifenacin—Loss of consciousness—Clonidine—glaucoma	0.000234	0.000989	CcSEcCtD
Darifenacin—Feeling abnormal—Brinzolamide—glaucoma	0.000234	0.000986	CcSEcCtD
Darifenacin—Mental disorder—Betaxolol—glaucoma	0.000234	0.000986	CcSEcCtD
Darifenacin—Pain—Pilocarpine—glaucoma	0.000233	0.000983	CcSEcCtD
Darifenacin—Constipation—Pilocarpine—glaucoma	0.000233	0.000983	CcSEcCtD
Darifenacin—Cough—Clonidine—glaucoma	0.000233	0.000982	CcSEcCtD
Darifenacin—Sweating—Timolol—glaucoma	0.000233	0.000982	CcSEcCtD
Darifenacin—Dizziness—Apraclonidine—glaucoma	0.000233	0.000981	CcSEcCtD
Darifenacin—Abdominal pain—Dorzolamide—glaucoma	0.000228	0.000962	CcSEcCtD
Darifenacin—Sinusitis—Timolol—glaucoma	0.000228	0.000961	CcSEcCtD
Darifenacin—Dysgeusia—Betaxolol—glaucoma	0.000227	0.000959	CcSEcCtD
Darifenacin—Arthralgia—Clonidine—glaucoma	0.000227	0.000958	CcSEcCtD
Darifenacin—Abdominal pain—Travoprost—glaucoma	0.000227	0.000958	CcSEcCtD
Darifenacin—Asthenia—Acetazolamide—glaucoma	0.000226	0.000952	CcSEcCtD
Darifenacin—Dizziness—Bimatoprost—glaucoma	0.000226	0.000951	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000225	0.000951	CcSEcCtD
Darifenacin—Feeling abnormal—Pilocarpine—glaucoma	0.000225	0.000947	CcSEcCtD
Darifenacin—Vomiting—Apraclonidine—glaucoma	0.000224	0.000944	CcSEcCtD
Darifenacin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000223	0.00094	CcSEcCtD
Darifenacin—Hypersensitivity—Brimonidine—glaucoma	0.000222	0.000939	CcSEcCtD
Darifenacin—Dry mouth—Clonidine—glaucoma	0.000222	0.000937	CcSEcCtD
Darifenacin—Dermatitis—Apraclonidine—glaucoma	0.000222	0.000935	CcSEcCtD
Darifenacin—Headache—Apraclonidine—glaucoma	0.00022	0.00093	CcSEcCtD
Darifenacin—Confusional state—Clonidine—glaucoma	0.000219	0.000926	CcSEcCtD
Darifenacin—Vision blurred—Betaxolol—glaucoma	0.000219	0.000923	CcSEcCtD
Darifenacin—Rhinitis—Timolol—glaucoma	0.000218	0.000921	CcSEcCtD
Darifenacin—Oedema—Clonidine—glaucoma	0.000218	0.000918	CcSEcCtD
Darifenacin—Hallucination—Timolol—glaucoma	0.000217	0.000915	CcSEcCtD
Darifenacin—Asthenia—Brimonidine—glaucoma	0.000217	0.000914	CcSEcCtD
Darifenacin—Infection—Clonidine—glaucoma	0.000216	0.000912	CcSEcCtD
Darifenacin—Abdominal pain—Pilocarpine—glaucoma	0.000215	0.000909	CcSEcCtD
Darifenacin—Diarrhoea—Acetazolamide—glaucoma	0.000215	0.000908	CcSEcCtD
Darifenacin—Rash—Bimatoprost—glaucoma	0.000215	0.000907	CcSEcCtD
Darifenacin—Dermatitis—Bimatoprost—glaucoma	0.000215	0.000906	CcSEcCtD
Darifenacin—Oedema peripheral—Timolol—glaucoma	0.000215	0.000905	CcSEcCtD
Darifenacin—Shock—Clonidine—glaucoma	0.000214	0.000903	CcSEcCtD
Darifenacin—Pruritus—Brimonidine—glaucoma	0.000214	0.000901	CcSEcCtD
Darifenacin—Headache—Bimatoprost—glaucoma	0.000214	0.000901	CcSEcCtD
Darifenacin—Nervous system disorder—Clonidine—glaucoma	0.000213	0.0009	CcSEcCtD
Darifenacin—Hypersensitivity—Dorzolamide—glaucoma	0.000212	0.000896	CcSEcCtD
Darifenacin—Tachycardia—Clonidine—glaucoma	0.000212	0.000896	CcSEcCtD
Darifenacin—Hypersensitivity—Travoprost—glaucoma	0.000212	0.000893	CcSEcCtD
Darifenacin—Skin disorder—Clonidine—glaucoma	0.000211	0.000892	CcSEcCtD
Darifenacin—Hyperhidrosis—Clonidine—glaucoma	0.00021	0.000888	CcSEcCtD
Darifenacin—Visual impairment—Timolol—glaucoma	0.00021	0.000886	CcSEcCtD
Darifenacin—Nausea—Apraclonidine—glaucoma	0.000209	0.000882	CcSEcCtD
Darifenacin—Hypersensitivity—Brinzolamide—glaucoma	0.000209	0.000881	CcSEcCtD
Darifenacin—Syncope—Betaxolol—glaucoma	0.000208	0.000878	CcSEcCtD
Darifenacin—Dizziness—Acetazolamide—glaucoma	0.000208	0.000878	CcSEcCtD
Darifenacin—Asthenia—Dorzolamide—glaucoma	0.000207	0.000873	CcSEcCtD
Darifenacin—Asthenia—Travoprost—glaucoma	0.000206	0.000869	CcSEcCtD
Darifenacin—Palpitations—Betaxolol—glaucoma	0.000205	0.000866	CcSEcCtD
Darifenacin—Pruritus—Dorzolamide—glaucoma	0.000204	0.000861	CcSEcCtD
Darifenacin—Loss of consciousness—Betaxolol—glaucoma	0.000204	0.000861	CcSEcCtD
Darifenacin—Eye disorder—Timolol—glaucoma	0.000204	0.000859	CcSEcCtD
Darifenacin—Asthenia—Brinzolamide—glaucoma	0.000203	0.000858	CcSEcCtD
Darifenacin—Pruritus—Travoprost—glaucoma	0.000203	0.000857	CcSEcCtD
Darifenacin—Cough—Betaxolol—glaucoma	0.000203	0.000855	CcSEcCtD
Darifenacin—Nausea—Bimatoprost—glaucoma	0.000203	0.000855	CcSEcCtD
Darifenacin—Hypersensitivity—Pilocarpine—glaucoma	0.000201	0.000847	CcSEcCtD
Darifenacin—Pruritus—Brinzolamide—glaucoma	0.000201	0.000846	CcSEcCtD
Darifenacin—Vomiting—Acetazolamide—glaucoma	0.0002	0.000844	CcSEcCtD
Darifenacin—Dizziness—Brimonidine—glaucoma	0.0002	0.000843	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000198	0.000837	CcSEcCtD
Darifenacin—Angiopathy—Timolol—glaucoma	0.000198	0.000834	CcSEcCtD
Darifenacin—Arthralgia—Betaxolol—glaucoma	0.000198	0.000834	CcSEcCtD
Darifenacin—Diarrhoea—Dorzolamide—glaucoma	0.000197	0.000833	CcSEcCtD
Darifenacin—Headache—Acetazolamide—glaucoma	0.000197	0.000832	CcSEcCtD
Darifenacin—Insomnia—Clonidine—glaucoma	0.000197	0.00083	CcSEcCtD
Darifenacin—Diarrhoea—Travoprost—glaucoma	0.000196	0.000829	CcSEcCtD
Darifenacin—Mediastinal disorder—Timolol—glaucoma	0.000196	0.000828	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000196	0.000828	CcSEcCtD
Darifenacin—Asthenia—Pilocarpine—glaucoma	0.000196	0.000825	CcSEcCtD
Darifenacin—Dyspnoea—Clonidine—glaucoma	0.000194	0.000819	CcSEcCtD
Darifenacin—Diarrhoea—Brinzolamide—glaucoma	0.000194	0.000818	CcSEcCtD
Darifenacin—Somnolence—Clonidine—glaucoma	0.000193	0.000816	CcSEcCtD
Darifenacin—Dry mouth—Betaxolol—glaucoma	0.000193	0.000816	CcSEcCtD
Darifenacin—Pruritus—Pilocarpine—glaucoma	0.000193	0.000813	CcSEcCtD
Darifenacin—Confusional state—Betaxolol—glaucoma	0.000191	0.000806	CcSEcCtD
Darifenacin—Mental disorder—Timolol—glaucoma	0.000191	0.000805	CcSEcCtD
Darifenacin—Dizziness—Dorzolamide—glaucoma	0.000191	0.000805	CcSEcCtD
Darifenacin—Rash—Brimonidine—glaucoma	0.00019	0.000803	CcSEcCtD
Darifenacin—Dermatitis—Brimonidine—glaucoma	0.00019	0.000803	CcSEcCtD
Darifenacin—Dizziness—Travoprost—glaucoma	0.00019	0.000801	CcSEcCtD
Darifenacin—Oedema—Betaxolol—glaucoma	0.000189	0.000799	CcSEcCtD
Darifenacin—Headache—Brimonidine—glaucoma	0.000189	0.000798	CcSEcCtD
Darifenacin—Infection—Betaxolol—glaucoma	0.000188	0.000794	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Clonidine—glaucoma	0.000188	0.000793	CcSEcCtD
Darifenacin—Dizziness—Brinzolamide—glaucoma	0.000187	0.000791	CcSEcCtD
Darifenacin—Nausea—Acetazolamide—glaucoma	0.000187	0.000789	CcSEcCtD
Darifenacin—Diarrhoea—Pilocarpine—glaucoma	0.000186	0.000787	CcSEcCtD
Darifenacin—Shock—Betaxolol—glaucoma	0.000186	0.000786	CcSEcCtD
Darifenacin—Pain—Clonidine—glaucoma	0.000186	0.000785	CcSEcCtD
Darifenacin—Constipation—Clonidine—glaucoma	0.000186	0.000785	CcSEcCtD
Darifenacin—Nervous system disorder—Betaxolol—glaucoma	0.000186	0.000784	CcSEcCtD
Darifenacin—Dysgeusia—Timolol—glaucoma	0.000186	0.000784	CcSEcCtD
Darifenacin—Tachycardia—Betaxolol—glaucoma	0.000185	0.00078	CcSEcCtD
Darifenacin—Skin disorder—Betaxolol—glaucoma	0.000184	0.000776	CcSEcCtD
Darifenacin—Vomiting—Dorzolamide—glaucoma	0.000183	0.000774	CcSEcCtD
Darifenacin—Hyperhidrosis—Betaxolol—glaucoma	0.000183	0.000773	CcSEcCtD
Darifenacin—Rash—Dorzolamide—glaucoma	0.000182	0.000767	CcSEcCtD
Darifenacin—Dermatitis—Dorzolamide—glaucoma	0.000182	0.000766	CcSEcCtD
Darifenacin—Rash—Travoprost—glaucoma	0.000181	0.000764	CcSEcCtD
Darifenacin—Dermatitis—Travoprost—glaucoma	0.000181	0.000763	CcSEcCtD
Darifenacin—Headache—Dorzolamide—glaucoma	0.000181	0.000762	CcSEcCtD
Darifenacin—Vomiting—Brinzolamide—glaucoma	0.00018	0.000761	CcSEcCtD
Darifenacin—Dizziness—Pilocarpine—glaucoma	0.00018	0.00076	CcSEcCtD
Darifenacin—Headache—Travoprost—glaucoma	0.00018	0.000759	CcSEcCtD
Darifenacin—Nausea—Brimonidine—glaucoma	0.000179	0.000757	CcSEcCtD
Darifenacin—Feeling abnormal—Clonidine—glaucoma	0.000179	0.000757	CcSEcCtD
Darifenacin—Rash—Brinzolamide—glaucoma	0.000179	0.000754	CcSEcCtD
Darifenacin—Vision blurred—Timolol—glaucoma	0.000179	0.000754	CcSEcCtD
Darifenacin—Dermatitis—Brinzolamide—glaucoma	0.000179	0.000754	CcSEcCtD
Darifenacin—Gastrointestinal pain—Clonidine—glaucoma	0.000178	0.000751	CcSEcCtD
Darifenacin—Headache—Brinzolamide—glaucoma	0.000178	0.000749	CcSEcCtD
Darifenacin—Angioedema—Timolol—glaucoma	0.000173	0.000731	CcSEcCtD
Darifenacin—Vomiting—Pilocarpine—glaucoma	0.000173	0.000731	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000173	0.000728	CcSEcCtD
Darifenacin—Abdominal pain—Clonidine—glaucoma	0.000172	0.000726	CcSEcCtD
Darifenacin—Rash—Pilocarpine—glaucoma	0.000172	0.000725	CcSEcCtD
Darifenacin—Dermatitis—Pilocarpine—glaucoma	0.000172	0.000724	CcSEcCtD
Darifenacin—Insomnia—Betaxolol—glaucoma	0.000171	0.000723	CcSEcCtD
Darifenacin—Nausea—Dorzolamide—glaucoma	0.000171	0.000723	CcSEcCtD
Darifenacin—Headache—Pilocarpine—glaucoma	0.000171	0.00072	CcSEcCtD
Darifenacin—Nausea—Travoprost—glaucoma	0.000171	0.00072	CcSEcCtD
Darifenacin—Syncope—Timolol—glaucoma	0.00017	0.000718	CcSEcCtD
Darifenacin—Dyspnoea—Betaxolol—glaucoma	0.000169	0.000713	CcSEcCtD
Darifenacin—Nausea—Brinzolamide—glaucoma	0.000168	0.000711	CcSEcCtD
Darifenacin—Palpitations—Timolol—glaucoma	0.000168	0.000707	CcSEcCtD
Darifenacin—Dyspepsia—Betaxolol—glaucoma	0.000167	0.000704	CcSEcCtD
Darifenacin—Loss of consciousness—Timolol—glaucoma	0.000167	0.000703	CcSEcCtD
Darifenacin—Cough—Timolol—glaucoma	0.000165	0.000698	CcSEcCtD
Darifenacin—Hypertension—Timolol—glaucoma	0.000164	0.000691	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000164	0.00069	CcSEcCtD
Darifenacin—Pain—Betaxolol—glaucoma	0.000162	0.000684	CcSEcCtD
Darifenacin—Constipation—Betaxolol—glaucoma	0.000162	0.000684	CcSEcCtD
Darifenacin—Nausea—Pilocarpine—glaucoma	0.000162	0.000683	CcSEcCtD
Darifenacin—Arthralgia—Timolol—glaucoma	0.000161	0.000681	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00016	0.000677	CcSEcCtD
Darifenacin—Hypersensitivity—Clonidine—glaucoma	0.00016	0.000676	CcSEcCtD
Darifenacin—Dry mouth—Timolol—glaucoma	0.000158	0.000666	CcSEcCtD
Darifenacin—Asthenia—Clonidine—glaucoma	0.000156	0.000659	CcSEcCtD
Darifenacin—Feeling abnormal—Betaxolol—glaucoma	0.000156	0.000659	CcSEcCtD
Darifenacin—Confusional state—Timolol—glaucoma	0.000156	0.000658	CcSEcCtD
Darifenacin—Oedema—Timolol—glaucoma	0.000155	0.000653	CcSEcCtD
Darifenacin—Anaphylactic shock—Timolol—glaucoma	0.000155	0.000653	CcSEcCtD
Darifenacin—Pruritus—Clonidine—glaucoma	0.000154	0.00065	CcSEcCtD
Darifenacin—Infection—Timolol—glaucoma	0.000154	0.000649	CcSEcCtD
Darifenacin—Shock—Timolol—glaucoma	0.000152	0.000642	CcSEcCtD
Darifenacin—Nervous system disorder—Timolol—glaucoma	0.000152	0.00064	CcSEcCtD
Darifenacin—Skin disorder—Timolol—glaucoma	0.00015	0.000634	CcSEcCtD
Darifenacin—Hyperhidrosis—Timolol—glaucoma	0.00015	0.000631	CcSEcCtD
Darifenacin—Diarrhoea—Clonidine—glaucoma	0.000149	0.000628	CcSEcCtD
Darifenacin—Dizziness—Clonidine—glaucoma	0.000144	0.000607	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Timolol—glaucoma	0.000141	0.000595	CcSEcCtD
Darifenacin—Insomnia—Timolol—glaucoma	0.00014	0.000591	CcSEcCtD
Darifenacin—Hypersensitivity—Betaxolol—glaucoma	0.00014	0.000589	CcSEcCtD
Darifenacin—Vomiting—Clonidine—glaucoma	0.000138	0.000584	CcSEcCtD
Darifenacin—Dyspnoea—Timolol—glaucoma	0.000138	0.000582	CcSEcCtD
Darifenacin—Somnolence—Timolol—glaucoma	0.000138	0.000581	CcSEcCtD
Darifenacin—Rash—Clonidine—glaucoma	0.000137	0.000579	CcSEcCtD
Darifenacin—Dermatitis—Clonidine—glaucoma	0.000137	0.000578	CcSEcCtD
Darifenacin—Headache—Clonidine—glaucoma	0.000136	0.000575	CcSEcCtD
Darifenacin—Dyspepsia—Timolol—glaucoma	0.000136	0.000575	CcSEcCtD
Darifenacin—Asthenia—Betaxolol—glaucoma	0.000136	0.000574	CcSEcCtD
Darifenacin—Pruritus—Betaxolol—glaucoma	0.000134	0.000566	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Timolol—glaucoma	0.000134	0.000564	CcSEcCtD
Darifenacin—Pain—Timolol—glaucoma	0.000132	0.000558	CcSEcCtD
Darifenacin—Diarrhoea—Betaxolol—glaucoma	0.00013	0.000547	CcSEcCtD
Darifenacin—Nausea—Clonidine—glaucoma	0.000129	0.000545	CcSEcCtD
Darifenacin—Feeling abnormal—Timolol—glaucoma	0.000128	0.000538	CcSEcCtD
Darifenacin—Gastrointestinal pain—Timolol—glaucoma	0.000127	0.000534	CcSEcCtD
Darifenacin—Dizziness—Betaxolol—glaucoma	0.000125	0.000529	CcSEcCtD
Darifenacin—Abdominal pain—Timolol—glaucoma	0.000122	0.000516	CcSEcCtD
Darifenacin—Vomiting—Betaxolol—glaucoma	0.00012	0.000508	CcSEcCtD
Darifenacin—Rash—Betaxolol—glaucoma	0.000119	0.000504	CcSEcCtD
Darifenacin—Dermatitis—Betaxolol—glaucoma	0.000119	0.000504	CcSEcCtD
Darifenacin—Headache—Betaxolol—glaucoma	0.000119	0.000501	CcSEcCtD
Darifenacin—Hypersensitivity—Timolol—glaucoma	0.000114	0.000481	CcSEcCtD
Darifenacin—Nausea—Betaxolol—glaucoma	0.000113	0.000475	CcSEcCtD
Darifenacin—Asthenia—Timolol—glaucoma	0.000111	0.000469	CcSEcCtD
Darifenacin—Pruritus—Timolol—glaucoma	0.00011	0.000462	CcSEcCtD
Darifenacin—Diarrhoea—Timolol—glaucoma	0.000106	0.000447	CcSEcCtD
Darifenacin—Dizziness—Timolol—glaucoma	0.000102	0.000432	CcSEcCtD
Darifenacin—Vomiting—Timolol—glaucoma	9.84e-05	0.000415	CcSEcCtD
Darifenacin—Rash—Timolol—glaucoma	9.76e-05	0.000412	CcSEcCtD
Darifenacin—Dermatitis—Timolol—glaucoma	9.75e-05	0.000411	CcSEcCtD
Darifenacin—Headache—Timolol—glaucoma	9.7e-05	0.000409	CcSEcCtD
Darifenacin—Nausea—Timolol—glaucoma	9.19e-05	0.000388	CcSEcCtD
Darifenacin—CHRM5—GPCR ligand binding—SMO—glaucoma	2.55e-05	0.00314	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—C3—glaucoma	2.54e-05	0.00312	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	2.51e-05	0.00308	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	2.47e-05	0.00303	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—LRP12—glaucoma	2.46e-05	0.00302	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	2.45e-05	0.00301	CbGpPWpGaD
Darifenacin—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	2.35e-05	0.00289	CbGpPWpGaD
Darifenacin—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	2.34e-05	0.00288	CbGpPWpGaD
Darifenacin—CYP2D6—Biological oxidations—GSTT1—glaucoma	2.33e-05	0.00286	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.31e-05	0.00284	CbGpPWpGaD
Darifenacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.28e-05	0.0028	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—OPN4—glaucoma	2.24e-05	0.00275	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—OPN4—glaucoma	2.23e-05	0.00274	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.21e-05	0.00272	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—OPN4—glaucoma	2.21e-05	0.00271	CbGpPWpGaD
Darifenacin—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.16e-05	0.00266	CbGpPWpGaD
Darifenacin—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.16e-05	0.00265	CbGpPWpGaD
Darifenacin—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.14e-05	0.00262	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.1e-05	0.00258	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.1e-05	0.00257	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—OPN4—glaucoma	2.03e-05	0.0025	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—OPN4—glaucoma	2.03e-05	0.00249	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.02e-05	0.00248	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	2.02e-05	0.00248	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	2.01e-05	0.00247	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—OPN4—glaucoma	2.01e-05	0.00246	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	1.99e-05	0.00244	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—FAS—glaucoma	1.97e-05	0.00241	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.93e-05	0.00237	CbGpPWpGaD
Darifenacin—CYP2D6—Biological oxidations—CYP1B1—glaucoma	1.85e-05	0.00227	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PTGFR—glaucoma	1.83e-05	0.00225	CbGpPWpGaD
Darifenacin—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	1.83e-05	0.00224	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PTGFR—glaucoma	1.82e-05	0.00224	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PTGFR—glaucoma	1.81e-05	0.00222	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—SMO—glaucoma	1.8e-05	0.00221	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—SMO—glaucoma	1.79e-05	0.0022	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—OPN4—glaucoma	1.78e-05	0.00219	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—SMO—glaucoma	1.78e-05	0.00218	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—EDN1—glaucoma	1.76e-05	0.00216	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—LRP12—glaucoma	1.73e-05	0.00213	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LRP12—glaucoma	1.73e-05	0.00212	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LRP12—glaucoma	1.71e-05	0.0021	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—OPN4—glaucoma	1.71e-05	0.00209	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—C3—glaucoma	1.69e-05	0.00207	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—EDN1—glaucoma	1.68e-05	0.00207	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HEYL—glaucoma	1.66e-05	0.00203	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NARFL—glaucoma	1.63e-05	0.002	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CA5A—glaucoma	1.63e-05	0.002	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTGFR—glaucoma	1.6e-05	0.00197	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HEYL—glaucoma	1.59e-05	0.00195	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.56e-05	0.00191	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.55e-05	0.00191	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.54e-05	0.00189	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—C3—glaucoma	1.54e-05	0.00189	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTGFR—glaucoma	1.54e-05	0.00189	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.52e-05	0.00187	CbGpPWpGaD
Darifenacin—CYP2D6—Biological oxidations—GSTM1—glaucoma	1.48e-05	0.00182	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—C3—glaucoma	1.47e-05	0.00181	CbGpPWpGaD
Darifenacin—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	1.46e-05	0.00179	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—SMO—glaucoma	1.37e-05	0.00168	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.36e-05	0.00167	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.36e-05	0.00167	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.34e-05	0.00165	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CA1—glaucoma	1.33e-05	0.00163	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—SMO—glaucoma	1.31e-05	0.00161	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CTSA—glaucoma	1.29e-05	0.00158	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RPTOR—glaucoma	1.26e-05	0.00154	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CA2—glaucoma	1.22e-05	0.00149	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NCK2—glaucoma	1.22e-05	0.00149	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.21e-05	0.00149	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RPTOR—glaucoma	1.2e-05	0.00148	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—OPN4—glaucoma	1.2e-05	0.00147	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—OPN4—glaucoma	1.2e-05	0.00147	CbGpPWpGaD
Darifenacin—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.19e-05	0.00147	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—EDN1—glaucoma	1.19e-05	0.00146	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—OPN4—glaucoma	1.19e-05	0.00146	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—EDN1—glaucoma	1.18e-05	0.00145	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.18e-05	0.00145	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—EDN1—glaucoma	1.17e-05	0.00144	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NCK2—glaucoma	1.16e-05	0.00143	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HEYL—glaucoma	1.12e-05	0.00137	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HEYL—glaucoma	1.11e-05	0.00137	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HEYL—glaucoma	1.1e-05	0.00135	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTGFR—glaucoma	1.08e-05	0.00133	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTGFR—glaucoma	1.08e-05	0.00132	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.07e-05	0.00131	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CA5A—glaucoma	1.07e-05	0.00131	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NARFL—glaucoma	1.07e-05	0.00131	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—C3—glaucoma	1.04e-05	0.00127	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HDAC9—glaucoma	1.03e-05	0.00127	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—C3—glaucoma	1.03e-05	0.00127	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—C3—glaucoma	1.02e-05	0.00126	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.01e-05	0.00124	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—EDN1—glaucoma	9.94e-06	0.00122	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HDAC9—glaucoma	9.9e-06	0.00122	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—GSTM1—glaucoma	9.69e-06	0.00119	CbGpPWpGaD
Darifenacin—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	9.55e-06	0.00117	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—EDN1—glaucoma	9.52e-06	0.00117	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—SMO—glaucoma	9.23e-06	0.00113	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—SMO—glaucoma	9.2e-06	0.00113	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—SMO—glaucoma	9.11e-06	0.00112	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—EDN1—glaucoma	9.03e-06	0.00111	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—C3—glaucoma	8.68e-06	0.00107	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—EDN1—glaucoma	8.64e-06	0.00106	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—TXN—glaucoma	8.58e-06	0.00105	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RPTOR—glaucoma	8.46e-06	0.00104	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RPTOR—glaucoma	8.44e-06	0.00104	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RPTOR—glaucoma	8.35e-06	0.00103	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—C3—glaucoma	8.32e-06	0.00102	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NCK2—glaucoma	8.2e-06	0.00101	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NCK2—glaucoma	8.17e-06	0.001	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NCK2—glaucoma	8.09e-06	0.000993	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SMO—glaucoma	8.09e-06	0.000993	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CA1—glaucoma	7.96e-06	0.000977	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—C3—glaucoma	7.89e-06	0.000968	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SMO—glaucoma	7.75e-06	0.000951	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CTSA—glaucoma	7.71e-06	0.000946	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—C3—glaucoma	7.55e-06	0.000927	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NTRK2—glaucoma	7.4e-06	0.000908	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—TP53—glaucoma	7.36e-06	0.000904	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CA2—glaucoma	7.28e-06	0.000894	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NTRK2—glaucoma	7.08e-06	0.00087	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HDAC9—glaucoma	6.97e-06	0.000856	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HDAC9—glaucoma	6.95e-06	0.000853	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HDAC9—glaucoma	6.88e-06	0.000845	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—EDN1—glaucoma	6.7e-06	0.000823	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—EDN1—glaucoma	6.68e-06	0.00082	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GSTT1—glaucoma	6.65e-06	0.000817	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—EDN1—glaucoma	6.62e-06	0.000812	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NGFR—glaucoma	6.35e-06	0.000779	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—EDN1—glaucoma	6.09e-06	0.000747	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NGFR—glaucoma	6.08e-06	0.000746	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—EDN1—glaucoma	6.07e-06	0.000745	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NTRK1—glaucoma	6.03e-06	0.00074	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—EDN1—glaucoma	6.01e-06	0.000738	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—C3—glaucoma	5.86e-06	0.000719	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—C3—glaucoma	5.84e-06	0.000717	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—C3—glaucoma	5.78e-06	0.00071	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NTRK1—glaucoma	5.77e-06	0.000709	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CDKN2B—glaucoma	5.56e-06	0.000682	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SMO—glaucoma	5.45e-06	0.00067	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SMO—glaucoma	5.44e-06	0.000667	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SMO—glaucoma	5.38e-06	0.000661	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—EDN1—glaucoma	5.33e-06	0.000655	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CDKN2B—glaucoma	5.32e-06	0.000653	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—C3—glaucoma	5.32e-06	0.000653	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—C3—glaucoma	5.3e-06	0.000651	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CYP1B1—glaucoma	5.3e-06	0.000651	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ABCA1—glaucoma	5.3e-06	0.000651	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—C3—glaucoma	5.25e-06	0.000644	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CA1—glaucoma	5.2e-06	0.000639	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—TXN—glaucoma	5.13e-06	0.00063	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—EDN1—glaucoma	5.11e-06	0.000627	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CTSA—glaucoma	5.04e-06	0.000619	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NTRK2—glaucoma	4.99e-06	0.000612	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NTRK2—glaucoma	4.97e-06	0.00061	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NTRK2—glaucoma	4.92e-06	0.000605	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NGF—glaucoma	4.9e-06	0.000602	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CA2—glaucoma	4.76e-06	0.000584	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NGF—glaucoma	4.69e-06	0.000576	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—C3—glaucoma	4.66e-06	0.000572	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—C3—glaucoma	4.46e-06	0.000548	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APOE—glaucoma	4.34e-06	0.000532	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CAV1—glaucoma	4.3e-06	0.000528	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NGFR—glaucoma	4.28e-06	0.000525	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NGFR—glaucoma	4.27e-06	0.000524	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GSTM1—glaucoma	4.24e-06	0.00052	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NGFR—glaucoma	4.22e-06	0.000519	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APOE—glaucoma	4.15e-06	0.00051	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CAV1—glaucoma	4.11e-06	0.000505	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—FN1—glaucoma	4.09e-06	0.000502	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NTRK1—glaucoma	4.07e-06	0.000499	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NTRK1—glaucoma	4.05e-06	0.000498	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—BAD—glaucoma	4.04e-06	0.000496	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NTRK1—glaucoma	4.01e-06	0.000493	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTT1—glaucoma	3.98e-06	0.000488	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—FN1—glaucoma	3.92e-06	0.000481	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—BAD—glaucoma	3.87e-06	0.000475	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDKN2B—glaucoma	3.75e-06	0.00046	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MTHFR—glaucoma	3.74e-06	0.00046	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDKN2B—glaucoma	3.74e-06	0.000459	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDKN2B—glaucoma	3.7e-06	0.000454	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EDN1—glaucoma	3.6e-06	0.000441	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EDN1—glaucoma	3.58e-06	0.00044	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EDN1—glaucoma	3.55e-06	0.000436	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—APOE—glaucoma	3.49e-06	0.000428	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CAV1—glaucoma	3.45e-06	0.000424	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TXN—glaucoma	3.35e-06	0.000412	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NGF—glaucoma	3.3e-06	0.000406	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NGF—glaucoma	3.29e-06	0.000404	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NGF—glaucoma	3.26e-06	0.0004	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NOS3—glaucoma	3.25e-06	0.000399	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP1B1—glaucoma	3.17e-06	0.000389	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCA1—glaucoma	3.17e-06	0.000389	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—C3—glaucoma	3.14e-06	0.000386	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—C3—glaucoma	3.13e-06	0.000384	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NOS3—glaucoma	3.11e-06	0.000382	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—C3—glaucoma	3.1e-06	0.000381	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOE—glaucoma	2.92e-06	0.000359	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOE—glaucoma	2.91e-06	0.000358	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CAV1—glaucoma	2.9e-06	0.000356	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CAV1—glaucoma	2.89e-06	0.000355	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOE—glaucoma	2.89e-06	0.000354	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CAV1—glaucoma	2.86e-06	0.000351	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CDKN1B—glaucoma	2.81e-06	0.000346	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FN1—glaucoma	2.76e-06	0.000339	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FN1—glaucoma	2.75e-06	0.000337	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BAD—glaucoma	2.72e-06	0.000335	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FN1—glaucoma	2.72e-06	0.000334	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BAD—glaucoma	2.72e-06	0.000333	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CDKN1B—glaucoma	2.7e-06	0.000331	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BAD—glaucoma	2.69e-06	0.00033	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—NOS3—glaucoma	2.61e-06	0.000321	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—glaucoma	2.61e-06	0.00032	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTT1—glaucoma	2.6e-06	0.000319	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTM1—glaucoma	2.53e-06	0.000311	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—glaucoma	2.5e-06	0.000306	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—glaucoma	2.39e-06	0.000293	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VEGFA—glaucoma	2.34e-06	0.000287	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.24e-06	0.000275	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MTHFR—glaucoma	2.24e-06	0.000275	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOS3—glaucoma	2.19e-06	0.000269	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOS3—glaucoma	2.18e-06	0.000268	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOS3—glaucoma	2.16e-06	0.000266	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOE—glaucoma	2.08e-06	0.000256	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP1B1—glaucoma	2.07e-06	0.000254	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCA1—glaucoma	2.07e-06	0.000254	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAV1—glaucoma	2.07e-06	0.000254	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDKN1B—glaucoma	1.9e-06	0.000233	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDKN1B—glaucoma	1.89e-06	0.000232	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDKN1B—glaucoma	1.87e-06	0.00023	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—glaucoma	1.77e-06	0.000217	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—glaucoma	1.76e-06	0.000216	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—glaucoma	1.75e-06	0.000215	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—glaucoma	1.73e-06	0.000213	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—glaucoma	1.69e-06	0.000208	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTM1—glaucoma	1.66e-06	0.000203	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VEGFA—glaucoma	1.58e-06	0.000194	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VEGFA—glaucoma	1.57e-06	0.000193	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NOS3—glaucoma	1.56e-06	0.000192	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VEGFA—glaucoma	1.56e-06	0.000191	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MTHFR—glaucoma	1.46e-06	0.00018	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—glaucoma	1.43e-06	0.000175	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOE—glaucoma	1.36e-06	0.000167	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAV1—glaucoma	1.35e-06	0.000166	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—glaucoma	1.19e-06	0.000146	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—glaucoma	1.19e-06	0.000146	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—glaucoma	1.18e-06	0.000145	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NOS3—glaucoma	1.02e-06	0.000125	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—glaucoma	9.34e-07	0.000115	CbGpPWpGaD
